Jason Haas

LGND

Jason Haas serves as director at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$3.74M

Net Position

Net Seller

$3.74M

Companies Traded

LGND

Active Period

Jun 2026 – Aug 2026

2 total trades

Most Recent

Sell LGND

Aug 14, 2026 · $2.09M

Jason Haas's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

2 · $3.74M

Total Shares Bought

Total Shares Sold

13,599

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 14, 2026	Sell	7,138	$292.81	$2.09M	3,981
Jun 15, 2026	Sell	6,461	$255.58	$1.65M	8,442

Related Insiders

Martine Zimmermann

director

LGNDSell · Sep 14, 2026

Andrew Reardon

officer: CLO & Secretary

LGNDSell · Sep 8, 2026

Octavio Espinoza

officer: Chief Financial Officer

LGNDSell · Aug 14, 2026

Stephen L Sabba

director

LGNDSell · Jun 18, 2026

LAMATTINA JOHN L

Director

LGNDSell · Jun 12, 2026

Jason Aryeh

Director

LGNDSell · Jun 12, 2026

KOZARICH JOHN W

Director

LGNDSell · May 14, 2026

Nancy Ryan Gray

Director

LGNDSell · Nov 12, 2025

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity